Beijing Institute of Radiation Medicine
Adenoviral-mediated gene transfer results in cytotoxicity of multiple myeloma cells
Published in Oncology Business Week, March 12th, 2006
According to recent research published in the journal Cancer Immunology, Immunotherapy, "Multiple myeloma (MM) remains incurable despite the use of high-dose chemotherapy and stem cell transplantation. However, immunotherapy is expected to offer long-term disease control, or even possibly a cure."
"We have previously demonstrated the suppressive effect of a recombinant adenovirus carrying human wild-type p53, granulocyte-macrophage colony-stimulating factor, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- AEterna Zentaris, Inc.
Cancer drug developer's strategic shareholder exercises right to convert loan - Access Pharmaceuticals, Inc.
Tumor therapy developer completes $5M convertible offering - Biopro Baden-Wuerttemberg GmbH
German software founder invests EUR 22 million in Tuebingen cancer-focused biotech company - Breast Cancer
Alliance publishes international breast health guidelines for developing countries - Bulgarian Academy of Sciences, Sofia
New findings in the area of prostate cancer vaccines described - Calando Pharmaceuticals, Inc.
Alliance forged with U.S. National Cancer Institute to develop RNAi therapeutics - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
